A detailed history of Fmr LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fmr LLC holds 4,833,684 shares of BPMC stock, worth $430 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,833,684
Previous 5,169,517 6.5%
Holding current value
$430 Million
Previous $490 Million 6.24%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$85.18 - $108.78 $28.6 Million - $36.5 Million
-335,833 Reduced 6.5%
4,833,684 $521 Million
Q1 2024

May 13, 2024

BUY
$73.17 - $99.79 $60.1 Million - $81.9 Million
821,206 Added 18.89%
5,169,517 $490 Million
Q4 2023

Feb 13, 2024

SELL
$43.96 - $92.84 $76.4 Million - $161 Million
-1,736,944 Reduced 28.54%
4,348,311 $401 Million
Q3 2023

Nov 13, 2023

SELL
$46.9 - $66.0 $29.2 Million - $41.1 Million
-622,882 Reduced 9.29%
6,085,255 $306 Million
Q2 2023

Aug 11, 2023

SELL
$42.2 - $66.37 $89.2 Million - $140 Million
-2,113,985 Reduced 23.96%
6,708,137 $424 Million
Q1 2023

May 11, 2023

SELL
$37.97 - $50.0 $5.79 Million - $7.62 Million
-152,423 Reduced 1.7%
8,822,122 $397 Million
Q4 2022

Feb 13, 2023

BUY
$41.06 - $66.48 $682,376 - $1.1 Million
16,619 Added 0.19%
8,974,545 $393 Million
Q3 2022

Nov 10, 2022

BUY
$49.93 - $77.7 $19.1 Million - $29.7 Million
381,847 Added 4.45%
8,957,926 $590 Million
Q2 2022

Aug 12, 2022

BUY
$45.23 - $70.15 $147 Million - $227 Million
3,242,698 Added 60.8%
8,576,079 $433 Million
Q1 2022

May 13, 2022

BUY
$54.1 - $110.08 $161 Million - $329 Million
2,984,929 Added 127.1%
5,333,381 $341 Million
Q4 2021

Feb 14, 2022

SELL
$94.25 - $115.99 $81.4 Million - $100 Million
-863,512 Reduced 26.88%
2,348,452 $252 Million
Q3 2021

Nov 15, 2021

SELL
$80.98 - $109.47 $84.1 Million - $114 Million
-1,038,167 Reduced 24.43%
3,211,964 $330 Million
Q2 2021

Aug 13, 2021

BUY
$82.78 - $101.0 $352 Million - $429 Million
4,250,131 New
4,250,131 $374 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.31B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.